Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and Mangoceuticals (NASDAQ:MGRX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.
Valuation & Earnings
This table compares Alignment Healthcare and Mangoceuticals”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $4.94 billion | 0.30 | -$720,000.00 | $0.13 | 55.35 |
| Mangoceuticals | $315,227.00 | 10.67 | -$20.64 million | ($1.01) | -0.15 |
Alignment Healthcare has higher revenue and earnings than Mangoceuticals. Mangoceuticals is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by company insiders. Comparatively, 16.0% of Mangoceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility & Risk
Alignment Healthcare has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of current ratings for Alignment Healthcare and Mangoceuticals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 1 | 6 | 6 | 0 | 2.38 |
| Mangoceuticals | 1 | 0 | 0 | 0 | 1.00 |
Alignment Healthcare presently has a consensus target price of $14.00, suggesting a potential upside of 94.58%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, equities analysts clearly believe Alignment Healthcare is more favorable than Mangoceuticals.
Profitability
This table compares Alignment Healthcare and Mangoceuticals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.59% | 12.46% | 2.36% |
| Mangoceuticals | -4,794.60% | -96.39% | -89.60% |
Summary
Alignment Healthcare beats Mangoceuticals on 11 of the 14 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc. is a technology-enabled healthcare company focused primarily on serving older adults through Medicare Advantage plans. Its health plans, offered under the Alignment Health Plan name, combine insurance coverage with care coordination and support intended to address members’ medical and everyday health needs. The company uses a care model that includes personalized care teams, member support and technology to help coordinate services across providers. Its Medicare Advantage offerings include plan options such as HMO and PPO products, with availability and benefits varying by location.
About Mangoceuticals
Mangoceuticals, Inc. is a men’s health and wellness company that offers telehealth services through its online platform. The platform connects customers with healthcare providers for consultations and, when appropriate, prescription treatments. The company’s offerings have included treatments for erectile dysfunction, hair loss and testosterone-related concerns, as well as weight-management services. Prescriptions are fulfilled through pharmacy partners. Mangoceuticals primarily serves customers in the United States through its digital platform.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
